NCT06011889View on ClinicalTrials.gov

Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 4, 2024

Primary Completion Date

October 18, 2028

Study Completion Date

October 18, 2028

Conditions
SAPHO Syndrome
Interventions
DRUG

Etanercept

treatment with etanercept in addition to NSAID treatment and/or classic Disease Modifying Antirheumatic Drugs

DRUG

Placebo

treatment with placebo in addition to NSAID treatment and/or classic Disease Modifying Antirheumatic Drugs

Trial Locations (1)

02-637

RECRUITING

Centrum Wsparcia Badań Klinicznych, Warsaw

Sponsors
All Listed Sponsors
collaborator

Medical Research Agency, Poland

OTHER_GOV

lead

National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

NETWORK

NCT06011889 - Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome | Biotech Hunter | Biotech Hunter